Dana Friesen, CEO of Summit Sciences, brings over 15 years of experience in financial analysis and ROI optimization within the medical device sector. The firm has delivered billions in lifetime ...

Research about LENN -- a patent-pending, virus-mimicking platform technology that targets bladder cancer cells with mRNA ...

NEW YORK, Jan. 12, 2026 /PRNewswire/ -- The Lung Cancer Research Foundation (LCRF) announced today that its 2026 funding opportunities are officially open for applications.

Men with newly diagnosed multiple myeloma are twice as likely as women to have stage III disease, with more kidney damage and ...

A new drug candidate shows promise by reversing cognitive decline in advanced Alzheimer's disease by restoring brain balance ...

A study that was published in recent weeks has given the world a sobering view of the number of cancer diagnoses that are ...

We are excited to release the distilled version of Wan2.2 video generation model family, which offers the following advantages: Wan2.2-I2V-A14B-NFE4-V1 Image-to-Video I2V-V1-WF I2V-V1-WF ...

A large national and international study has identified dozens of blood proteins linked to prostate cancer risk, some shared across populations, some unique to specific groups. Published in Nature ...

Abstract: The utilization of incremental models is a straightforward and effective method to improve the robustness of model predictive control (MPC). However, there ...

Microsoft Research and Providence Health have effectively bypassed the high cost of precision oncology, releasing an AI model on Tuesday that generates complex protein data from standard tissue slides ...

Christian Pilarsky vividly remembers the moment, in 2022, when he realized that his technique for modelling pancreatic cancer had finally worked. A molecular biologist at the University Hospital ...

The pancreatic cancer testing device has a similar appearance – credit, Getty Images for Unsplash + A quick and easy breath test to detect the difficult-to-diagnose pancreatic cancer is being trialed ...